Bon Secours Mercy Health and Lirio Announce Partnership and Investment
Health System and Artificial Intelligence Leader Collaborate to Drive Positive Behavior Change
Bon Secours Mercy Health and Lirio, LLC announced their new strategic partnership at the 38th annual J.P. Morgan Healthcare Conference, initiated by a direct investment from Bon Secours Mercy Health in Lirio’s innovative behavior change AI platform. John Starcher, president and CEO of Bon Secours Mercy Health will join Lirio’s board of directors.
“Together with Lirio, Bon Secours Mercy Health is leveraging leading edge technology to continuously learn from our patients, families and community members, which will allow us to translate that learning into personalized health programs and communications that empower individuals to make healthy decisions and take healthy actions,” said Justin McGoldrick, M.D., chief clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health of the communities we serve.”
Read More: How Artificial Intelligence And Blockchain Is Revolutionizing Mobile Industry In 2020?
Lirio and Bon Secours Mercy Health will co-develop new behavior change programs that influence health decision-making for those at risk for chronic diseases, such as diabetes and hypertension. These programs will eventually be marketed and sold to other health systems globally under commercial terms agreed to between both parties.
Bon Secours Mercy Health will license and deploy existing Lirio behavior change programs, such as women’s health programs and programs that encourage the use of digital engagement tools like patient portals.
Read More: Accenture Announces Changes to Its Growth Model and Global Management Committee
“Bon Secours Mercy Health has a bold vision for extending care beyond the hospital into the community and addressing root causes of poor health,” said Mike West, Lirio’s chairman and CEO. “We are excited to co-develop new behavior change programs that target at-risk populations proactively and preventatively in ways that both improve care quality and achieve operational efficiencies. By effectively utilizing large volumes of population health data, we can activate consumers by guiding them with personalized, data-driven health journeys.”
Bon Secours Mercy Health will now have access to Lirio’s deep talent pool of behavioral scientists, data scientists and AI researchers to join forces with its clinical experts in population health, data analytics and various community partnerships that address social determinants of health.
Read More: Allied Wallet China and Founder Andy Khawaja Plan to Implement Blockchain Technology in 2020
Comments are closed, but trackbacks and pingbacks are open.